|
⚲
|
| Keyboard |
| Powell Michael
✚
|
|
|---|---|
| CIK # | 0001202793 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001202793] | |
| 4 | [0001202793] | |
| 5 | [0001202793] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Grant | 23,746 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2023-06-14 | Grant | 64,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2022-06-15 | Grant | 20,000 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 30,000 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 10,030 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 30,000 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2021-08-09 | Grant | 30,000 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2021-06-16 | Grant | 10,030 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2021-06-16 | Grant | 13,179 | $0.00 | |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2021-05-18 | Buy | 727,272 | $11.00 | 7,999,992 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2021-05-18 | Conversion | 2,187,504 | ||
|
Vera Therapeutics Inc VERA
Series C Preferred Stock · derivative
|
2021-05-18 | Conversion | 2,187,504 | $0.00 | |
|
Bolt Biotherapeutics Inc BOLT
Series C-1 Preferred Stock · derivative
|
2021-02-09 | Conversion | 1,104,209 | $0.00 | |
|
Bolt Biotherapeutics Inc BOLT
Common Stock
|
2021-02-09 | Conversion | 1,104,209 | ||
|
Bolt Biotherapeutics Inc BOLT
Common Stock
|
2021-02-09 | Buy | 450,000 | $20.00 | 9,000,000 |
|
Bolt Biotherapeutics Inc BOLT
Common Stock
|
2021-02-09 | Conversion | 1,200,228 | ||
|
Bolt Biotherapeutics Inc BOLT
Series C-2 Preferred Stock · derivative
|
2021-02-09 | Conversion | 1,200,228 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2020-11-10 | Grant | 30,000 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Series A Preferred Stock · derivative
|
2020-08-11 | Conversion | 12,500,000 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Series C Preferred Stock · derivative
|
2020-08-11 | Conversion | 3,644,624 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||